国产精品成人嫩草影院-欧美精品成人a在线观看-国内精品久久久久久久久齐齐-国产精品99精品一区二区三区-色橹橹欧美在线观看视频高清

中文
中文
為了病患而驅(qū)動的創(chuàng)新
Patient-first cell therapy innovation
 

Breaking boundaries: Current progress of anticancer NK cell-based drug development
  • 0


Highlights

NK cells are safe in allogeneic applications and therefore are ideal off-the-shelf drugs.

NK cell-based therapeutics have shown satisfying safety profiles and promising efficiency in cancer treatment.

NK cells possess a reservoir of innate immune receptors targeting various types of cancer cells.

With proper engineering, NK cells can function as the universal anti-cancer drugs that are not restricted to HLA and cancer types.

 

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網(wǎng)安備 44011502000528號

粵ICP備20056630號 Powered by vancheer
關(guān)于天科雅
研究與發(fā)展
產(chǎn)品及臨床
新聞與媒體
招賢納士

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網(wǎng)安備 44011502000528號

粵ICP備20056630號 Powered by vancheer